Company registration number 9233570 (England and Wales)
EVERYLIFE TECHNOLOGIES LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 OCTOBER 2025
PAGES FOR FILING WITH REGISTRAR
EVERYLIFE TECHNOLOGIES LIMITED
CONTENTS
Page
Balance sheet
1 - 2
Notes to the financial statements
3 - 11
EVERYLIFE TECHNOLOGIES LIMITED
BALANCE SHEET
AS AT
31 OCTOBER 2025
31 October 2025
page 1
2025
2024
Notes
£
£
£
£
Fixed assets
Tangible assets
4
58,765
39,731
Current assets
Stocks
1,272
775
Debtors
5
584,141
656,083
Cash at bank and in hand
334,728
856,876
920,141
1,513,734
Creditors: amounts falling due within one year
6
(518,793)
(592,099)
Net current assets
401,348
921,635
Total assets less current liabilities
460,113
961,366
Creditors: amounts falling due after more than one year
7
(8,505,000)
(8,430,000)
Net liabilities
(8,044,887)
(7,468,634)
Capital and reserves
Called up share capital
10
7,514
7,514
Share premium account
11,473,358
11,473,358
Profit and loss reserves
(19,525,759)
(18,949,506)
Total equity
(8,044,887)
(7,468,634)
EVERYLIFE TECHNOLOGIES LIMITED
BALANCE SHEET (CONTINUED)
AS AT
31 OCTOBER 2025
31 October 2025
page 2
For the financial year ended 31 October 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.
The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true
The financial statements were approved by the board of directors and authorised for issue on 29 July 2026 and are signed on its behalf by:
R J H Batchelor
Director
Company registration number 9233570 (England and Wales)
EVERYLIFE TECHNOLOGIES LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 OCTOBER 2025
page 3
1
Accounting policies
Company information
everyLIFE Technologies Limited is a private company limited by shares incorporated in England and Wales. The registered office is A1 Ground Floor, East Wing, Cody Technology Park, Ively Road, Farnbourough, GU14 0LX.
1.1
Basis of preparation
These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.
The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.
The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.
1.2
Going concern
These financial statements are prepared on the going concern basis. The directors have a reasonable expectation that the company will continue in operational existence for the foreseeable future. However, the directors are aware of certain material uncertainties which may cause doubt on the company's ability to continue as a going concern.
At the balance sheet date, the company's liabilities exceeded its assets. The company has however received assurance from the directors that they will give financial support to the company as necessary for at least twelve months from the date of signing these financial statements. On this basis, the directors consider it appropriate to prepare the accounts on a going concern basis.
1.3
Revenue
Turnover represents the gross amounts billed to clients in respect of income earned and other client recharges, net of discounts, sales taxes, accrued, and deferred amounts. Each type of income is recognised on the following basis:
a) Sales of software licences are recognised once the licence has been granted and the customer has been provided with access to the software. Revenue derived from sales of licences is spread over the period of the licence. Where licences are perpetual, revenue is recognised in full once the agreement is in place.
b) Ongoing support and maintenance fees are spread over the period of the contract on a straight line basis.
c) Certain other services fees are recognised in the accounting periods in which work is performed.
1.4
Research and development expenditure
Research expenditure is written off against profits in the year in which it is incurred. Identifiable development expenditure is capitalised to the extent that the technical, commercial and financial feasibility can be demonstrated.
1.5
Tangible fixed assets
Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.
Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:
Computer equipment
33.33% Straight line
Cycle To Work Scheme
100% Straight line
EVERYLIFE TECHNOLOGIES LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 OCTOBER 2025
1
Accounting policies
(Continued)
page 4
The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.
1.6
Impairment of fixed assets
At each reporting period end date, the company reviews the carrying amounts of its tangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). Where it is not possible to estimate the recoverable amount of an individual asset, the company estimates the recoverable amount of the cash-generating unit to which the asset belongs.
Recoverable amount is the higher of fair value less costs to sell and value in use. In assessing value in use, the estimated future cash flows are discounted to their present value using a pre-tax discount rate that reflects current market assessments of the time value of money and the risks specific to the asset for which the estimates of future cash flows have not been adjusted.
If the recoverable amount of an asset (or cash-generating unit) is estimated to be less than its carrying amount, the carrying amount of the asset (or cash-generating unit) is reduced to its recoverable amount. An impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the impairment loss is treated as a revaluation decrease.
Recognised impairment losses are reversed if, and only if, the reasons for the impairment loss have ceased to apply. Where an impairment loss subsequently reverses, the carrying amount of the asset (or cash-generating unit) is increased to the revised estimate of its recoverable amount, but so that the increased carrying amount does not exceed the carrying amount that would have been determined had no impairment loss been recognised for the asset (or cash-generating unit) in prior years. A reversal of an impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the reversal of the impairment loss is treated as a revaluation increase.
1.7
Stocks
Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the stocks to their present location and condition.
Stocks held for distribution at no or nominal consideration are measured at the lower of cost and replacement cost, adjusted where applicable for any loss of service potential.
At each reporting date, an assessment is made for impairment. Any excess of the carrying amount of stocks over its estimated selling price less costs to complete and sell is recognised as an impairment loss in profit or loss. Reversals of impairment losses are also recognised in profit or loss.
1.8
Cash and cash equivalents
Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.
1.9
Financial instruments
The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.
Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.
Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.
EVERYLIFE TECHNOLOGIES LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 OCTOBER 2025
1
Accounting policies
(Continued)
page 5
Basic financial assets
Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.
Other financial assets
Other financial assets, including investments in equity instruments which are not subsidiaries, associates or joint ventures, are initially measured at fair value, which is normally the transaction price. Such assets are subsequently carried at fair value and the changes in fair value are recognised in profit or loss, except that investments in equity instruments that are not publicly traded and whose fair values cannot be measured reliably are measured at cost less impairment.
Impairment of financial assets
Financial assets, other than those held at fair value through profit and loss, are assessed for indicators of impairment at each reporting end date.
Financial assets are impaired where there is objective evidence that, as a result of one or more events that occurred after the initial recognition of the financial asset, the estimated future cash flows have been affected. If an asset is impaired, the impairment loss is the difference between the carrying amount and the present value of the estimated cash flows discounted at the asset’s original effective interest rate. The impairment loss is recognised in profit or loss.
If there is a decrease in the impairment loss arising from an event occurring after the impairment was recognised, the impairment is reversed. The reversal is such that the current carrying amount does not exceed what the carrying amount would have been, had the impairment not previously been recognised. The impairment reversal is recognised in profit or loss.
Derecognition of financial assets
Financial assets are derecognised only when the contractual rights to the cash flows from the asset expire or are settled, or when the company transfers the financial asset and substantially all the risks and rewards of ownership to another entity, or if some significant risks and rewards of ownership are retained but control of the asset has transferred to another party that is able to sell the asset in its entirety to an unrelated third party.
Classification of financial liabilities
Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.
Basic financial liabilities
Basic financial liabilities, including creditors, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.
Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.
Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.
EVERYLIFE TECHNOLOGIES LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 OCTOBER 2025
1
Accounting policies
(Continued)
page 6
Other financial liabilities
Derivatives, including interest rate swaps and forward foreign exchange contracts, are not basic financial instruments. Derivatives are initially recognised at fair value on the date a derivative contract is entered into and are subsequently re-measured at their fair value. Changes in the fair value of derivatives are recognised in profit or loss in finance costs or finance income as appropriate, unless hedge accounting is applied and the hedge is a cash flow hedge.
Debt instruments that do not meet the conditions in FRS 102 paragraph 11.9 are subsequently measured at fair value through profit or loss. Debt instruments may be designated as being measured at fair value through profit or loss to eliminate or reduce an accounting mismatch or if the instruments are measured and their performance evaluated on a fair value basis in accordance with a documented risk management or investment strategy.
Derecognition of financial liabilities
Financial liabilities are derecognised when the company’s contractual obligations expire or are discharged or cancelled.
1.10
Equity instruments
Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.
1.11
Taxation
The tax expense represents the sum of the tax currently payable and deferred tax.
Current tax
The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.
Deferred tax
Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.
The carrying amount of deferred tax assets is reviewed at each reporting end date and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax is charged or credited in the profit and loss account, except when it relates to items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets and liabilities are offset when the company has a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities relate to taxes levied by the same tax authority.
1.12
Employee benefits
The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets.
The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.
Termination benefits are recognised immediately as an expense when the company is demonstrably committed to terminate the employment of an employee or to provide termination benefits.
1.13
Retirement benefits
Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.
1.14
Share-based payments
EVERYLIFE TECHNOLOGIES LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 OCTOBER 2025
1
Accounting policies
(Continued)
page 7
1.15
Leases
As lessee
Rentals payable under operating leases, including any lease incentives received, are charged to profit or loss on a straight line basis over the term of the relevant lease except where another more systematic basis is more representative of the time pattern in which economic benefits from the leased asset are consumed.
2
Judgements and key sources of estimation uncertainty
In the application of the company’s accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.
The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.
Critical judgements
The following judgements (apart from those involving estimates) have had the most significant effect on amounts recognised in the financial statements.
Impairment of Tangible assets
The directors were required to determine whether there are indicators of impairment of the company's tangible assets. Factors taken into consideration in reaching such a decision include the economic viability and expected future financial performance of the asset and where it is a component of a larger cash generating unit, the viability and expected future performance of that unit.
Key sources of estimation uncertainty
The estimates and assumptions which have a significant risk of causing a material adjustment to the carrying amount of assets and liabilities are as follows.
Property, plant and equipment (see note 4)
Tangible fixed assets are depreciated over their useful lives taking into account residual values, where appropriate. The actual lives of the assets and residual values are assessed annually and may vary depending on a number of factors. In re-assessing asset lives, factors such as technological innovation, product life cycles and maintenance programmes are taken into account. Residual value assessments consider issues such as future market conditions, the remaining life of the asset and projected disposal values.
Share options (see note 9)
Share options are valued at grant using the Black-Scholes valuation model. There is a degree of estimation and judgement made in valuing share based payments.
Development expenditure
The Directors have concluded that the criteria set out in accounting policy 1.4 have not been met sufficiently to justify capitalising the expenditure. In particular, there is insufficient evidence to support the expectation of future economic benefits arising from the expenditure incurred.
EVERYLIFE TECHNOLOGIES LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 OCTOBER 2025
page 8
3
Employees
The average monthly number of persons (including directors) employed by the company during the year was:
2025
2024
Number
Number
Total
64
67
4
Tangible fixed assets
Computer equipment
Cycle To Work Scheme
Total
£
£
£
Cost
At 1 November 2024
130,534
130,534
Additions
47,602
1,166
48,768
At 31 October 2025
178,136
1,166
179,302
Depreciation and impairment
At 1 November 2024
90,803
90,803
Depreciation charged in the year
29,151
583
29,734
At 31 October 2025
119,954
583
120,537
Carrying amount
At 31 October 2025
58,182
583
58,765
At 31 October 2024
39,731
39,731
5
Debtors
2025
2024
Amounts falling due within one year:
£
£
Trade debtors
215,365
201,713
Corporation tax recoverable
50,000
79,735
Other debtors
21,614
3,005
Prepayments and accrued income
297,162
371,630
584,141
656,083
EVERYLIFE TECHNOLOGIES LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 OCTOBER 2025
page 9
6
Creditors: amounts falling due within one year
2025
2024
£
£
Trade creditors
46,741
57,443
Taxation and social security
340,434
309,989
Deferred income
57,855
91,376
Other creditors
1,776
1,194
Accruals and deferred income
71,987
132,097
518,793
592,099
7
Creditors: amounts falling due after more than one year
2025
2024
£
£
Other borrowings
8,505,000
8,430,000
On 18 October 2019, a debenture was registered providing a fixed and floating charge over the assets of the company in favour of the majority equity owner in respects of amounts due on a revolving credit facility of £3,000,000. This has periodically increased and at the year end stands at £8,505,000 (2024 - £8,430,000). The loan is interest free.
8
Retirement benefit schemes
2025
2024
Defined contribution schemes
£
£
Charge to profit or loss in respect of defined contribution schemes
235,794
223,204
The company operates a defined contribution pension scheme for all qualifying employees. The assets of the scheme are held separately from those of the company in an independently administered fund. Contributions totalling £16,813 (2024 - £17,566) were payable to the fund at the reporting date and are included in other creditors.
9
Share-based payment transactions
A scheme was implemented on 1 November 2019, granting 150,000 shares to qualifying employees. The options have an exercise price of £1.65 per share. The only vesting condition is that the employees need to remain an employee of the company over the vesting dates. They are also required to notify HMRC 92 days prior to vesting.
Two new schemes were implemented on 2 May 2023 granting 620,000 share options to qualifying and non-qualifying employees. These options have an exercise price of £0.01 per share. During the year one employee forfeited 3,030 share options. The option shares shall vest immediately and shall become capable of exercise by the Option Holder 3 years after the Grant Date. The lapse date of this option is 1 May 2033.
The options granted are equity settled share based payments as there are no cash settlement alternatives.
EVERYLIFE TECHNOLOGIES LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 OCTOBER 2025
9
Share-based payment transactions
(Continued)
page 10
Number of share options
Weighted average exercise price
2025
2024
2025
2024
Number
Number
pence
pence
Outstanding at 1 November 2024
704,852
723,033
-
-
Granted
100,000
0.01
Forfeited
(118,181)
Outstanding at 31 October 2025
701,822
704,852
-
-
Exercisable at 31 October 2025
Liabilities and expenses
The total charge for the year for share based payments recognised in the Statement of Comprehensive Income is £Nil (2024 - £Nil).
10
Called up share capital
2025
2024
2025
2024
Ordinary share capital
Number
Number
£
£
Issued and fully paid
Ordinary shares of 0.1p each
7,513,650
7,513,650
7,514
7,514
Share purchase option:
On 28 January 2019 the company issued 2,500,000 Ordinary shares, with a nominal value of £0.001, at a price of £0.60 per share. The subscription agreement included an option to purchase a further 2,500,000 Ordinary shares at the same price. The expiration date of this option is 18 September 2029.
11
Operating lease commitments
As lessee
At the reporting end date the company had outstanding commitments for future minimum lease payments under non-cancellable operating leases, as follows:
2025
2024
£
£
Total commitments
25,639
79,182
12
Related party transactions
Transactions with related parties
During the year the company entered into the following transactions with related parties:
At the year end the amount owed to the majority equity owner by the company is £8,505,000 (2024 - £8,430,000). This is repayable in more than one year.
Two of the directors of everyLIFE Technologies Limited also sit as directors for the entity, Care Software Providers Association C.I.C (CASPA). An amount of £7,000 is due from CASPA at the year end (2024 - £7,000).
EVERYLIFE TECHNOLOGIES LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 OCTOBER 2025
page 11
13
Parent company
In the opinion of the directors, R Batchelor is the ultimate controlling party.
2025-10-312024-11-01falsefalsefalse29 July 2026CCH SoftwareCCH Accounts Production 2026.100No description of principal activityR J H BatchelorD S CampbellT L GatawaN D MossR Rana92335702024-11-012025-10-3192335702025-10-3192335702024-10-319233570core:ComputerEquipment2025-10-319233570core:Non-standardPPEClass1ComponentTotalPropertyPlantEquipment2025-10-319233570core:ComputerEquipment2024-10-319233570core:Non-standardPPEClass1ComponentTotalPropertyPlantEquipment2024-10-319233570core:CurrentFinancialInstrumentscore:WithinOneYear2025-10-319233570core:CurrentFinancialInstrumentscore:WithinOneYear2024-10-319233570core:Non-currentFinancialInstrumentscore:AfterOneYear2025-10-319233570core:Non-currentFinancialInstrumentscore:AfterOneYear2024-10-319233570core:ShareCapital2025-10-319233570core:ShareCapital2024-10-319233570core:SharePremium2025-10-319233570core:SharePremium2024-10-319233570core:RetainedEarningsAccumulatedLosses2025-10-319233570core:RetainedEarningsAccumulatedLosses2024-10-319233570core:ShareCapitalOrdinaryShareClass12025-10-319233570core:ShareCapitalOrdinaryShareClass12024-10-319233570bus:Director12024-11-012025-10-319233570core:ComputerEquipment2024-11-012025-10-319233570core:Non-standardPPEClass1ComponentTotalPropertyPlantEquipment2024-11-012025-10-3192335702023-11-012024-10-319233570core:ComputerEquipment2024-10-319233570core:Non-standardPPEClass1ComponentTotalPropertyPlantEquipment2024-10-3192335702024-10-319233570core:CurrentFinancialInstruments2025-10-319233570core:CurrentFinancialInstruments2024-10-319233570core:Non-currentFinancialInstruments2025-10-319233570core:Non-currentFinancialInstruments2024-10-319233570bus:OrdinaryShareClass12024-11-012025-10-319233570bus:OrdinaryShareClass12025-10-319233570bus:OrdinaryShareClass12024-10-319233570bus:PrivateLimitedCompanyLtd2024-11-012025-10-319233570bus:SmallCompaniesRegimeForAccounts2024-11-012025-10-319233570bus:FRS1022024-11-012025-10-319233570bus:AuditExemptWithAccountantsReport2024-11-012025-10-319233570bus:Director22024-11-012025-10-319233570bus:Director32024-11-012025-10-319233570bus:Director42024-11-012025-10-319233570bus:CompanySecretary12024-11-012025-10-319233570bus:FullAccounts2024-11-012025-10-31xbrli:purexbrli:sharesiso4217:GBP